Same goal, Different molecular strategy – Which FVIIIa Mimetic Gets There How? – RPTH Journal
RPTH Journal shared a post on LinkedIn about a recent article by Jacob Lund et al, adding:
“Same goal. Different molecular strategy. Which FVIIIa mimetic gets there how?
This new RPTH study directly compares denecimig (Mim8), zemocimig (NXT007), and emicizumab under the same experimental conditions.
The next-generation mimetics take strikingly different routes:
- Zemocimig – highest FIXa–FX complex assembly affinity
- Denecimig – lower affinity, but dramatically higher catalytic activity
- Yet denecimig and zemocimig produced remarkably similar thrombin-generation profiles, with both showing greater potency than emicizumab.
Different engineering strategies – similar enhancement of hemostatic potential.
An intriguing mechanistic look at the evolving generation of FVIIIa-mimetic therapies for hemophilia A.”
Title: Mechanism of action and impact on thrombin generation of denecimig (Mim8), emicizumab, and zemocimig (NXT007): comparative analysis using sequence-identical analogs
Authors: Jacob Lund, Thomas Egebjerg, Jais Rose Bjelke, Mirella Ezban
More posts featuring RPTH Journal on Hemostasis Today.
-
Oct 18, 2026, 17:11Owen McCarty: Understanding Prekallikrein and Its Role in Inflammation and Thrombosis
-
Oct 18, 2026, 17:04Emna Gouider Belhadjali: Don’t Miss GPAS 2026 on Bleeding Disorders
-
Oct 18, 2026, 16:53Mehran Ghasemzadeh: Microparticle-Associated Mitochondrial DNA in Stored Platelet Products
-
Oct 18, 2026, 16:38Edward Lee Carter: A 15-Minute Blood Test for Brain Hemorrhage?
-
Oct 18, 2026, 16:29Patrick Taylor: Oral vs Transdermal Estrogen and Cardiovascular Risk in Menopausal Women
-
Oct 18, 2026, 16:19Artangela Henry: A Meaningful Week at the SCDAA National Convention
-
Oct 18, 2026, 16:04Emília Araújo։ New Insights Into the Genetics of Hemophilia B Leyden
-
Oct 18, 2026, 15:43André Marcel Harris: Award-Winning Research on Texas Sickle Cell Data Collection
-
Oct 18, 2026, 15:21Eleonora Gambineri: First Results of the IEI-Haem Consortium at ESID 2026